The Microarray-Based Approach for the Analysis of the Transcriptome
- 30 June 2014
- book chapter
- Published by Springer Nature
- Vol. 1186, 131-199
Abstract
Microarrays play an important role in the study of the transcriptome in a variety of conditions and species. This is documented by their widespread use over the last decade in areas such as cancer, immunology, neurological disorders, renal diseases, and many others, directed towards the new frontiers of personalized medicine and drug discovery. The following method covers a specific application of microarrays in the field of immunology, focusing on the study of antigen-induced T cell differentiation in response to viral or bacterial infection, and in the context of cancer. This protocol allows, through an “Omics” strategy, the study of the transcriptome of CTLs, concentrating only on the expression profiles of those genes more likely to be involved in CTL action. Since the biological question, in this case, is very specific, the advantage of this protocol with respect to a more traditional whole transcriptome microarray experiment is to remove the noise coming from all the genes not directly involved in the CTLs-specific pathways, highlighting weaker signals that otherwise would be hidden by the noise itself. To address this issue we have accurately selected all the CTLs-specific pathways, extracted all the genes belonging to them, and designed a CTL-specific microarray, based on all known validated transcripts deriving from these genes. This microarray has been built for the Agilent Technologies microarray platform, the only one that, to our knowledge, at present allows autonomously designing a completely customizable microarray. We used it in the context of renal cell carcinoma (RCC), but surely it will find several more applications in many other cancers and in the context of viral and bacterial infection.Keywords
This publication has 12 references indexed in Scilit:
- Identifying Key Regulatory Genes in the Whole Blood of Septic Patients to Monitor Underlying Immune DysfunctionsShock, 2013
- Prediction of Disease-free Survival in Hepatocellular Carcinoma by Gene Expression ProfilingAnnals of Surgical Oncology, 2013
- Transcriptome analysis using next-generation sequencingCurrent Opinion in Biotechnology, 2013
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- From Traditional Biomarkers to Transcriptome Analysis in Drug DevelopmentCurrent Molecular Medicine, 2005
- DNA Array-Based Gene ProfilingAnnals of Surgery, 2005
- Genome-Scale Gene Function Prediction Using Multiple Sources of High-Throughput Data in Yeast Saccharomyces cerevisiaeOMICS: A Journal of Integrative Biology, 2004
- Transcription profiling of gene expression in drug discovery and development: the NCI experienceEuropean Journal of Cancer, 2004
- Gene expression microarray technologies in the development of new therapeutic agentsEuropean Journal of Cancer, 2004
- A comprehensive transcript index of the human genome generated using microarrays and computational approachesGenome Biology, 2004